5,600 Shares in Danaher Corporation $DHR Purchased by Ratan Capital Management LP

Key Points

• Ratan Capital Management acquired 5,600 Danaher shares worth approximately $1.07 million in the second quarter. Institutional investors collectively own 79.05% of the company.
• Danaher reported quarterly earnings of $1.94 per share, beating estimates by $0.09, while revenue rose 5.5% year over year to $6.26 billion.
• Analysts maintain a “Moderate Buy” consensus rating with an average price target of $228.91, compared with the stock’s reported price of $216.41.

Ratan Capital Management LP acquired a new stake in Danaher Corporation (NYSE:DHR - Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 5,600 shares of the conglomerate's stock, valued at approximately $1,067,000.

Other institutional investors also recently added to or reduced their stakes in the company. BlackRock Inc. purchased a new position in shares of Danaher during the 2nd quarter worth approximately $10,492,520,000. Norges Bank purchased a new stake in shares of Danaher in the fourth quarter valued at approximately $2,177,106,000. Jupiter Topco LLC purchased a new stake in shares of Danaher in the second quarter valued at approximately $1,456,317,000. Generation Investment Management LLP acquired a new position in Danaher during the second quarter worth $1,287,949,000. Finally, Bank of America Corp DE purchased a new position in Danaher in the second quarter worth $993,846,000. Hedge funds and other institutional investors own 79.05% of the company's stock.

Danaher Stock Up 0.3%

DHR opened at $216.41 on Friday. The business's fifty day moving average is $199.46 and its two-hundred day moving average is $192.52. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. The company has a market cap of $152.13 billion, a price-to-earnings ratio of 38.44, a PEG ratio of 2.69 and a beta of 0.78. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80.

Danaher (NYSE:DHR - Get Free Report) last posted its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating the consensus estimate of $1.85 by $0.09. The company had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.Danaher's revenue was up 5.5% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.77 earnings per share. Analysts anticipate that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts have commented on DHR shares. HSBC reduced their target price on Danaher from $270.00 to $230.00 and set a "buy" rating for the company in a report on Wednesday, June 3rd. Weiss Ratings upgraded shares of Danaher from a "sell (d+)" rating to a "hold (c-)" rating in a report on Wednesday, July 15th. Piper Sandler started coverage on shares of Danaher in a research note on Thursday, June 11th. They issued a "neutral" rating and a $200.00 price objective for the company. Wells Fargo & Company decreased their price objective on shares of Danaher from $212.00 to $195.00 and set an "equal weight" rating on the stock in a report on Wednesday, July 22nd. Finally, TD Cowen lowered their target price on shares of Danaher from $240.00 to $236.00 and set a "buy" rating on the stock in a research report on Wednesday, July 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $228.91.

Danaher Company Profile

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source